Yahoo Finance 
GLOBAL BOTULINUM TOXIN MARKET FORECAST 2021-2028
KEY FINDINGS The global botulinum toxin market is anticipated to project a CAGR of 5. 14% during the forecast years of 2021 to 2028. The market growth is supplemented by leading factors, including the increased demand for aesthetic procedures, the rising patient preference for non-invasive or minimally invasive treatments, and the expansion of botulinum toxin into therapeutic applications.
New York, May 04, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "GLOBAL BOTULINUM TOXIN MARKET FORECAST 2021-2028" - https://www.reportlinker.com/p06067982/?utm_source=GNW
MARKET INSIGHTS
Botulinum toxin entails a neurotoxic protein produced by the bacterium Clostridium botulinum as well as related species. The protein prevents the neurotransmitter acetylcholine’s release from axon endings located at the neuromuscular junction, thereby causing flaccid paralysis.
The surging demand for modern beauty standards has resulted in a tremendous growth platform for botulinum toxin products globally.The therapeutic applications for botulinum toxins have also led to increased developments across healthcare platforms.
As per the National Clinical Trial (NCT) Registry, more than 80 ongoing and planned clinical trials associated with botulinum toxin are currently underway in diverse phases of development for various indications, as of October 2020.This factor is expected to positively impact the global market’s growth.
Moreover, the high demand for botulinum toxin facilitates several product innovations, in addition to a subsequent rise in the number of product launches worldwide.
REGIONAL INSIGHTS
The global botulinum toxin market growth is assessed through the evaluation of North America, Europe, the Asia-Pacific, and the Rest of World.The Asia-Pacific is set to be the fastest-growing market for botulinum toxin, owing to drivers such as the surging geriatric population, the increasing awareness and interest in aesthetic procedures, and the growing purchasing power of the middle class on account of economic development.
Furthermore, the market is highly diverse due to varied regulatory factors, leading to differences in product availability across countries.
COMPETITIVE INSIGHTS
Merz Pharma, Galderma SA, AbbVie Inc (Allergan), etc., are among the key companies operating in the global market.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Companies mentioned
1. ABBVIE INC (ALLERGAN PLC)
2. EVOLUS INC
3. GALDERMA PHARMA SA (ACQUIRED BY EQT)
4. HUGEL INC
5. IPSEN PHARMA
6. MEDYTOX INC
7. MERZ PHARMA
8. REVANCE THERAPEUTICS INC
9. US WORLDMEDS LLC
Read the full report: https://www.reportlinker.com/p06067982/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
